HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I. Swerdlow, Rudi G. J. Westendorp, Christina Lee Chung et al.|The Lancet|2014Cited by 709
Age at Menopause, Cause-Specific Mortality and Total Life ExpectancyMarlies E. Ossewaarde, Yvonne T. van der Schouw|Epidemiology|2005Cited by 434
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F. Schmidt, Andrzej Pająk, Daniel I. Swerdlow et al.|The Lancet Diabetes & Endocrinology|2016Cited by 390
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studiesLisa Pennells, Torben Jørgensen, Stephen Kaptoge et al.|European Heart Journal|2018Cited by 166
Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countriesJu‐Sheng Zheng, Nicholas J. Wareham, Stephen J. Sharp et al.|BMJ|2020Cited by 161